Mesoblast Limited (MSB):企業概要、財務及び戦略的SWOT分析

◆英語タイトル:Mesoblast Limited (MSB) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH61698FSA
◆発行会社(調査会社):GlobalData
◆発行日:2015年1月9日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD300 ⇒換算¥33,300見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD600 ⇒換算¥66,600見積依頼/購入/質問フォーム
Global Site License(複数国内共有可)USD900 ⇒換算¥99,900見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary

Mesoblast Limited (Mesoblast) is a biotechnology company. The company focuses on developing novel biotherapeutics using its cell-based technologies for the treatment of a wide range of diseases. Its technology platforms include Mesenchymal Precursor Cells (MPCs), Mesenchymal Stem Cells (MSCs), Dental Pulp Stem Cells (DPSCs) and Hematopoietic Stem Cells (HSCs). Mesoblast serves various therapeutic areas such as immunologic/ inflammatory, cardiac vascular, spine disease, ophthalmolog, neurologic and oncology. The company has partnership with Teva Pharmaceutical Industries Ltd., JCR Pharmaceuticals Co. Ltd. and Lonza Group. It has operational presence in the US and Singapore. Mesoblast is headquartered in Melbourne, Victoria, Australia.

Mesoblast Limited Key Recent Developments

Nov 25, 2013: New Japanese Regenerative Medicine Legislation and Commercial Opportunities for Stem Cell Products
Aug 29, 2013: Mesoblast’s Strong Cash Position Enables Execution of Late-Stage Clinical Trials
Jul 18, 2013: Mesoblast Receives $4.3 Million from Australian Government for Adult Stem Cell Pipeline Development
Jun 05, 2013: Mesoblast Obtains Key Japanese Patent Covering Mesenchymal Precursor Cells
Feb 13, 2013: Mesoblast Announces FDA Agreement On Its Use Of Singapore Manufacturing Facility For Clinical Trial Production Of Mesenchymal Precursor Cells

This comprehensive SWOT profile of Mesoblast Limited provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Mesoblast Limited including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Mesoblast Limited – Key Information
Mesoblast Limited – Overview
Mesoblast Limited – Key Employees
Mesoblast Limited – Key Employee Biographies
Mesoblast Limited – Key Operational Heads
Mesoblast Limited – Major Products and Services
Mesoblast Limited – History
Mesoblast Limited – Company Statement
Mesoblast Limited – Locations And Subsidiaries
Mesoblast Limited – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Mesoblast Limited – Business Description
Mesoblast Limited – Corporate Strategy
Mesoblast Limited – SWOT Analysis
SWOT Analysis – Overview
Mesoblast Limited – Strengths
Mesoblast Limited – Weaknesses
Mesoblast Limited – Opportunities
Mesoblast Limited – Threats
Mesoblast Limited – Key Competitors

Section 3 – Company Financial Performance Charts

Mesoblast Limited – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Mesoblast Limited, Key Information
Mesoblast Limited, Key Ratios
Mesoblast Limited, Share Data
Mesoblast Limited, Major Products and Services
Mesoblast Limited, History
Mesoblast Limited, Key Employees
Mesoblast Limited, Key Employee Biographies
Mesoblast Limited, Key Operational Heads
Mesoblast Limited, Other Locations
Mesoblast Limited, Subsidiaries
Mesoblast Limited, Key Manufacturing facilities
Mesoblast Limited, Key Competitors
Mesoblast Limited, SWOT Analysis
Mesoblast Limited, Ratios based on current share price
Mesoblast Limited, Annual Ratios
Mesoblast Limited, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Mesoblast Limited, Performance Chart
Mesoblast Limited, Ratio Charts

★海外企業調査レポート[Mesoblast Limited (MSB):企業概要、財務及び戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • RCS MediaGroup S.p.A:企業のM&A・提携・投資分析
    RCS MediaGroup S.p.A - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's RCS MediaGroup S.p.A Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • PT Unggul Indah Cahaya Tbk (UNIC):企業概要、財務及び戦略的SWOT分析
    Summary PT Unggul Indah Cahaya Tbk (UIC) is a chemical company. The company manufactures alkylbenzene chemicals. Its products include alkylbenzene, heavy and light alkylate, sodium tripolyphospate, linear alkylbenzene sulfonic acid, sodium tripolyphosphate, phosphoric acid, food phosphates and blend …
  • Ybrant Digital Limited (formerly Ybrant Technologies Limited):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Ybrant Digital Limited (formerl …
  • Teco Energy Inc-エネルギー分野:企業M&A・提携分析
    Summary TECO Energy Inc (TECO), a subsidiary of Emera Inc., is an energy holding company for regulated electricity and gas utilities and other businesses. It generates, transmits, distributes, purchases and sells electricity; and purchases, distributes and sells natural gas through its subsidiaries. …
  • Novatek Microelectronics Corp. (3034):企業概要、財務及び戦略的SWOT分析
    Summary Novatek Microelectronics Corp. (Novatek) is a fable chip design company. The company carries out design, development and sales of a wide range of display driver ICs & SoC solutions. Its products include display driver IC and SoC solutions. Novatek’s products are used for refined flat-panel d …
  • Tenaga Nasional Berhad (TENAGA)(エネルギー分野):企業M&A動向
    Summary Tenaga Nasional Berhad (TNB) is an integrated power company. The company operates business through three segments, namely, generation, transmission and distribution. It operates a portfolio of assets covering thermal stations and major hydroelectric schemes in Peninsular Malaysia. TNB manage …
  • Mesa Laboratories Inc (MLAB)-医療機器分野:企業M&A・提携分析
    Summary Mesa Laboratories Inc (Mesa) is a medical device company that manufactures and markets validation and monitoring instruments. The company’s products comprise mesa biological indicators, DryCal gas flow calibrators, BGI ambient particulate sampling, DialyGuard dialysate meters, SureTorque cap …
  • Ascendis Pharma AS (ASND)(製薬・医療分野):企業M&A動向
    Summary Ascendis Pharma A/S (Ascendis Pharma) is a biotechnology company. By utilizing its Transcon prodrug technology platform the company undertakes the development of high-value drugs in differentiated prodrug versions. It focuses on creating drug candidates, which are improved versions of existi …
  • Genable Technologies Ltd:企業のM&A・提携動向(医療分野)
    Summary Genable Technologies Ltd (Spark) formerly Genable Technologies Limited is a biopharmaceutical company that discovers, manufactures and distributes new gene therapies for the treatment of inherited genetic disorders. The company is developing gene based therapies for the treatment of heredita …
  • Universal Technical Institute, Inc. (UTI):企業財務及び戦略的SWOT分析
    Summary Universal Technical Institute, Inc. (UTI) is an educational institution that offers professional technical training. The institute provides education for students seeking careers as professional automotive, diesel, collision repair, motorcycle and marine technicians. It offers undergraduate …
  • SunPower Corporation (SPWR)(エネルギー分野):企業M&A動向
    Summary SunPower Corporation (SunPower) is a vertically integrated provider of solar products and solutions. It specializes in the design, development, manufacture and sale of solar systems. The company conducts business through three segments, namely, the Americas; the EMEA; and the APAC. SunPower’ …
  • EandA Limited:企業の戦略・SWOT・財務分析
    SummaryEandA Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findings …
  • Huntington Exploration Inc. (HEI):企業財務及び戦略的SWOT分析
    Summary Huntington Exploration Inc. (Huntington) is an oil and gas company that offers exploration services. The company explores, develops and operates oil and gas reserves. It has assets in core areas such as Atlee and Bindloss, Pine Creek, and Wizard Lake. Huntington produces heavy oil from Atlee …
  • Damodar Valley Corporation:企業のM&A・提携動向(発電分野)
    Summary Damodar Valley Corporation (DVC) is an energy utility company. It engages in power generation, transmission, water supply, mining, and rural electrification activities. Major businesses of the company include thermal, and hydroelectric power generation; and water supply for industrial and do …
  • FAR Limited (FAR):企業概要、財務及び戦略的SWOT分析
    Summary FAR Limited (FAR) is an oil and gas exploration company. The company provides exploration, development, production and acquisition of oil and natural gas. It has exploration assets in West and East Africa. FAR holds interests in nine exploration licenses with a combined gross area of approxi …
  • BlueScope Steel Limited:企業の戦略・SWOT・財務分析
    SummaryBlueScope Steel Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Geneva Bioinformatics (GeneBio) SA:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Geneva Bioinformatics (GeneBio) …
  • Bollinger, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Bollinger, Inc. Mergers and Acq …
  • Active Implants LLC:企業のM&A・提携動向(医療機器分野)
    Summary Active Implants LLC (Active Implants), formerly Active Implants Corporation is a medical device company that develops orthopedic equipment. The company develops and commercializes polymer orthopedic implants solutions such as tribofit hip system, tribofit instrumentation equipment, and NuSur …
  • Thai President Foods Plc (TF):企業の財務及び戦略的SWOT分析
    Summary Thai President Foods Plc (TF) is a food manufacturing company that is a manufacturer of instant noodles and biscuit products. Its products include crackers, wafers, cookies, and fruit juices. TF offers its biscuits products in different flavors such as butter coconut, butter coconut orange c …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆